RG foundation Heal the world

My prototype diagnostic device is a novel, saliva-based lateral flow assay designed to detect anti-gp120 antibodies—key indicators of early HIV exposure at mucosal surfaces. This non-invasive diagnostic tool has the potential to revolutionize early HIV detection, enhance prevention efforts, and support vaccine research by providing insight into mucosal immune responses.